Table 1. Titration Schedule.
<40 kg | ⩾40 kg | |
---|---|---|
Week | Dose | Dose |
Week 0, days 1–4 | 125 mg po QHS | 250 mg po QHS |
Week 0, days 5–7 | 125 mg po BID | 250 mg po BID |
Week 1, days 1–4 | 125 mg po QAM, 250 mg po QHS | 250 mg po QAM, 500 mg po QHS |
Week 1, days 5–7 | 250 mg po BID | 500 mg po BID |
Weeks 2–3 | Titrated to therapeutic drug levela | Titrated to therapeutic drug levela |
Weeks 4–12 | Maintained on therapeutic dose | Maintained on therapeutic dose |
Based on clinical response in conjunction with minimum valproate level (50 μg/ml).